Biaryl ether derivatives useful as monoamine reuptake inhibitors
US6410736B1 · kind B1 · utility
9Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2000 |
| Grant date | Jun 25, 2002 |
| Priority date | — |
| Expiry date | Oct 19, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I, and to their pharmaceutically acceptable salts. Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.